Spinal Tech

The first two patients to receive InVivo's Neuro-Spinal Scaffold for spinal cord injury are showing improvement three-to-six months after surgery.

LDR received an "outperform" rating by analysts at RBC Capital Markets, according to a Directors Talk report.

Here are the stock reports from five spine device companies for May 14, 2015 and how they compare to their numbers two weeks ago on April 30.

Spine device company K2M has grown significantly over the past few years, from a spine start-up focused on minimally invasive deformity techniques to a public company competing in multiple spinal technology spaces.

The North America internal trauma fixation devices market is projected to grow significantly over the next four years, according to a report from Research and Markets.

The consensus, or mean, target price of the Wall Street analysts covering NuVasive is $54.9, according to a Markets Daily report.

Ellipse Technologies received FDA 510(k) clearance to market its next generation external remote controller for use with the MAGnetic Expansion Control Spinal Bracing and Distraction System, or MAGEC system.

Pittsburgh-based Allegheny Health Network's has incorporated the MAKO RIO Robotic Arm Interactive Orthopedic System, according to a MD News report.

The Food and Drug Administration granted 22 spine device clearances in April.

The United States' orthopedic stem cell market was the fastest growing orthopedic biomaterial segment in the U.S. in 2014, according to an iData Research report.